Market Cap (In USD)
79.17 Million
Revenue (In USD)
-
Net Income (In USD)
-
Avg. Volume
243.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.0E-6-1.0E-4
- PE
- -
- EPS
- -
- Beta Value
- 1.984
- ISIN
- CA1806342061
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Robert Farrell J.D.
- Employee Count
- -
- Website
- https://claritaspharma.com
- Ipo Date
- 2016-04-12
- Details
- Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021. The company was founded in 2014 and is headquartered in San Rafael, California.
More Stocks
-
EMITFElbit Imaging Ltd.
EMITF
-
GROV
-
3020
-
MTW
-
600021
-
VENUSPIPESVenus Pipes and Tubes Limited
VENUSPIPES
-
KASHYAPKashyap Tele-Medicines Limited
KASHYAP
-
KOPRANKopran Limited
KOPRAN